About the Atypical Teratoid Session
Exploring the enigmatic realm of Atypical Teratoid Rhabdoid Tumor (ATRT) within the context of cancer research unveils a landscape both challenging and promising. This malignancy, primarily assaulting the pediatric population, manifests its aggressiveness in the brain and spinal cord, warranting a nuanced investigative approach. Researchers meticulously dissect the genetic labyrinth of ATRT, aiming to decipher its unique mutations and molecular cascades. This genetic unraveling serves as the cornerstone for crafting bespoke therapeutic strategies, potentially revolutionizing treatment paradigms. In the crucible of scientific inquiry, immunotherapy emerges as a beacon of hope, alongside the tailored precision of targeted therapies, illuminating the path towards improved patient outcomes. The collaborative synergy among researchers and clinicians becomes the linchpin in navigating the complexities of ATRT, propelling us closer to effective interventions against this formidable adversary.
Topics Covered in Atypical Teratoid
SMARCB1 Deficiency
Molecular Subgroups
Infant Brain Tumors
Rhabdoid Tumor Predisposition
High-Dose Chemotherapy
Conformal Radiotherapy
Related Scientific Sessions at CIOC 2027
Why Attend the Atypical Teratoid Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Atypical Teratoid work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Atypical Teratoid research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Atypical Teratoid track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Atypical Teratoid Conference 2027 — FAQs
What is the Atypical Teratoid track at CIOC 2027?
The Atypical Teratoid track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Atypical Teratoid. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Atypical Teratoid sessions?
Cancer researchers and clinicians, educators and students with an interest in Atypical Teratoid are all welcome — whether presenting or attending.
Can I present my research in the Atypical Teratoid track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Atypical Teratoid sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Atypical Teratoid track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.